追忆疗法对认知障碍的老年人认知功能的影响:随机对照试验的系统审查和元分析
Xuan Huang1, Cui Ye1, Ai Zhao2
1The First Affiliated Hospital of Soochow University, Suzhou, China; School of Nursing, Suzhou Medical College of Soochow University, Suzhou, China.
Archives of gerontology and geriatrics
|September 16, 2025
概括
追忆疗法显著提高了认知障碍的老年人的认知功能,特别是那些有轻度认知障碍 (MCI) 的人. 最佳的干预措施包括至少12周的每周小组会议,改善认知结果.
科学领域:
- 老年学是一门学科.
- 神经科学是一个神经科学.
- 心理治疗 心理治疗
背景情况:
- 认知障碍在老年人群中越来越令人担忧.
- 寻求非药物干预来改善老年人的认知功能.
- 回忆疗法为认知增强提供了一个潜在的途径.
研究的目的:
- 评估回忆疗法对有认知障碍的老年人认知功能的疗效.
- 确定回忆疗法干预的最佳参数,包括格式,持续时间,频率和周期.
主要方法:
- 随机对照试验 (RCT) 的系统审查和元分析.
- 搜索了多个数据库 (PubMed,科学网等) 在2024年10月之前.
- 使用柯克兰偏差风险工具 (ROB 2.0) 评估研究质量.
主要成果:
- 记忆疗法显著改善了认知功能 (SMD=1.15).
- 在亚洲参与者和轻度认知障碍 (MCI) 患者中观察到更大的益处.
- 最佳策略:每周进行一次小组会议 (>6名参与者),持续时间为30-45分钟,持续12周.
结论:
- 追忆疗法是一种有效的非药物干预,用于认知障碍的老年人进行认知改善.
- 推方案:每周进行一次小组会议 (30-45分钟,≥6名参与者),持续时间≥12周.
- 需要进一步进行高质量的研究,并进行更长的随访,以确认持续的影响.
相关概念视频
Cognitive Development During Adulthood
783
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
783
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
560
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
560
Alzheimer's Disease: Treatment
825
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
825
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Interference and Decay
421
Forgetting is a complex cognitive phenomenon influenced by several factors, among which interference and decay are particularly prominent. These processes explain why individuals often struggle to retrieve specific information from memory, leading to lapses in recall that can be observed in everyday situations.
Interference occurs when competing memories hinder the retrieval of particular information. It can be classified into two types: proactive and retroactive interference. Proactive...
Interference occurs when competing memories hinder the retrieval of particular information. It can be classified into two types: proactive and retroactive interference. Proactive...
421
False Memories
415
False memories represent a cognitive distortion in which individuals recall events that did not happen, or remember them in an altered form. This phenomenon highlights the brain's constructive nature in processing and recalling memories, emphasizing that memory is not a perfect representation of past events but rather a dynamic reconstruction influenced by various factors.
One primary source of false memories is misattribution, where individuals incorrectly associate external information...
One primary source of false memories is misattribution, where individuals incorrectly associate external information...
415


